Rajiv de Silva, Chief Operating Officer at VALEANT PHARMACEUTICALS INTERNATIONAL (VRX), sold 23,000 shares at $45.24 ($1.0M) on 2010-06-09, disclosed to the SEC on 2010-06-11.
Open-market sale of $1.0M VRX by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $45.24 | 4,662 | $211K | 20.3% |
| 2 | $45.24 | 18,338 | $830K | 79.7% |
| Total | $45.24 avg | 23,000 | $1.0M | 100% |
| Filing → |
| ENDP | BUY | 2015-11-12 | $500K | — | Filing → |
| VRX | SELL | 2012-11-09 | $4.1M | — | Filing → |
| VRX | SELL | 2012-11-08 | $12.0M | — | Filing → |